ArticleJournal of immunology research2018

Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study.

Fabio Massimo Perrotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.